294 related articles for article (PubMed ID: 9572002)
41. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone.
Yazaki Y; Isobe M; Hiroe M; Morimoto S; Hiramitsu S; Nakano T; Izumi T; Sekiguchi M;
Am J Cardiol; 2001 Nov; 88(9):1006-10. PubMed ID: 11703997
[TBL] [Abstract][Full Text] [Related]
42. An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment.
Judson MA
Chest; 1999 Apr; 115(4):1158-65. PubMed ID: 10208222
[TBL] [Abstract][Full Text] [Related]
43. [Sarcoidosis].
Huber-Geismann F; Franzen D; Russi E
Praxis (Bern 1994); 2012 Dec; 101(25):1595-605; quiz 1606-7. PubMed ID: 23233097
[No Abstract] [Full Text] [Related]
44. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Hoyer PF; Brodeh J
J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
[TBL] [Abstract][Full Text] [Related]
45. [Clinical characteristics of and the related factors to the relapse of chronic hepatitis B after lamivudine withdrawal].
Zhang XH; Lin GL; Zhu JY; Chen L; Yang SJ; Xiao JS
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):601-4. PubMed ID: 15504290
[TBL] [Abstract][Full Text] [Related]
46. The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis.
Rizzato G; Riboldi A; Imbimbo B; Torresin A; Milani S
Respir Med; 1997 Sep; 91(8):449-60. PubMed ID: 9338047
[TBL] [Abstract][Full Text] [Related]
47. Pulmonary sarcoidosis associated with etanercept therapy.
Farah RE; Shay MD
Pharmacotherapy; 2007 Oct; 27(10):1446-8. PubMed ID: 17896899
[TBL] [Abstract][Full Text] [Related]
48. Bone loss in prednisone treated sarcoidosis: a two-year follow-up.
Montemurro L; Fraioli P; Riboldi A; Delpiano S; Zanni D; Rizzato G
Ann Ital Med Int; 1990; 5(3 Pt 1):164-8. PubMed ID: 2288818
[TBL] [Abstract][Full Text] [Related]
49. Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids.
Fazzi P; Manni E; Cristofani R; Cei G; Piazza S; Calabrese R; Antonelli A; Siciliano G; Barachini P; Carpi A
Biomed Pharmacother; 2012 Jun; 66(4):300-7. PubMed ID: 22494798
[TBL] [Abstract][Full Text] [Related]
50. Risk factors of relapse in pulmonary sarcoidosis treated with corticosteroids.
Zheng Y; Wang H; Xu Q; Yan X; Zhuang Y; Jiang H; Meng F; Xiao Y; Cai H; Dai J
Clin Rheumatol; 2019 Jul; 38(7):1993-1999. PubMed ID: 30877493
[TBL] [Abstract][Full Text] [Related]
51. Sarcoid pleural effusion: a report of two cases.
Salazar A; Mañá J; Corbella X; Vidaller A
Sarcoidosis; 1994 Sep; 11(2):135-7. PubMed ID: 7809499
[TBL] [Abstract][Full Text] [Related]
52. Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis.
Sahoo DH; Bandyopadhyay D; Xu M; Pearson K; Parambil JG; Lazar CA; Chapman JT; Culver DA
Eur Respir J; 2011 Nov; 38(5):1145-50. PubMed ID: 21565914
[TBL] [Abstract][Full Text] [Related]
53. Bone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis.
Rizzato G; Tosi G; Schiraldi G; Montemurro L; Zanni D; Sisti S
Sarcoidosis; 1988 Sep; 5(2):99-103. PubMed ID: 3227195
[TBL] [Abstract][Full Text] [Related]
54. Sarcoidosis and central serous retinopathy: a dangerous combination.
Sharma OP; Rao N; Roy M
Sarcoidosis Vasc Diffuse Lung Dis; 1998 Sep; 15(2):189-91. PubMed ID: 9789899
[TBL] [Abstract][Full Text] [Related]
55. Treatment of sarcoidosis.
Selroos O
Sarcoidosis; 1994 Mar; 11(1):80-3. PubMed ID: 8036353
[TBL] [Abstract][Full Text] [Related]
56. Corticosteroid therapy increases HDL-cholesterol concentrations in patients with active sarcoidosis and hypoalphalipoproteinemia.
Salazar A; Mañá J; Pintó X; Argimón JM; Hurtado I; Pujol R
Clin Chim Acta; 2002 Jun; 320(1-2):59-64. PubMed ID: 11983201
[TBL] [Abstract][Full Text] [Related]
57. Methotrexate vs azathioprine in second-line therapy of sarcoidosis.
Vorselaars ADM; Wuyts WA; Vorselaars VMM; Zanen P; Deneer VHM; Veltkamp M; Thomeer M; van Moorsel CHM; Grutters JC
Chest; 2013 Sep; 144(3):805-812. PubMed ID: 23538719
[TBL] [Abstract][Full Text] [Related]
58. Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis.
Sakkat A; Cox G; Khalidi N; Larche M; Beattie K; Renzoni EA; Morar N; Kouranos V; Kolb M; Hambly N
Respir Res; 2022 Mar; 23(1):54. PubMed ID: 35264154
[TBL] [Abstract][Full Text] [Related]
59. Treatment of sarcoidosis with infliximab.
Doty JD; Mazur JE; Judson MA
Chest; 2005 Mar; 127(3):1064-71. PubMed ID: 15764796
[TBL] [Abstract][Full Text] [Related]
60. Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy. Outcome and complications.
Johns CJ; Schonfeld SA; Scott PP; Zachary JB; MacGregor MI
Ann N Y Acad Sci; 1986; 465():702-12. PubMed ID: 3460404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
